R&D

Pipeline

Combination Therapies

Pipeline
파이프라인 후보물질 전임상 임상1상 임상2상 임상3상 비고
MB-110(PDI inhibitors) Protein-DNA interaction inhibotor
MB-510(siRNA-therapeutics) Factor M siRNA 제작
MB-610(Drug repositioning) Known Factor M inhibitor

Companion Diagnostics

Pipeline
Biomarker
Selection		 Feasibility Prototype
Assay		 Analytical
Validation		 Clinical & Analytical
Validation		 Regulatory
Approval		 Post Approval
MB-CDx
검색 닫기